...
首页> 外文期刊>Xenobiotica: the fate of foreign compounds in biological systems >Effects of fibrates on human organic anion-transporting polypeptide 1B1-, multidrug resistance protein 2- and P-glycoprotein-mediated transport.
【24h】

Effects of fibrates on human organic anion-transporting polypeptide 1B1-, multidrug resistance protein 2- and P-glycoprotein-mediated transport.

机译:贝特类药物对人类有机阴离子转运多肽1B1,多药耐药蛋白2和P-糖蛋白介导的转运的影响。

获取原文
获取原文并翻译 | 示例

摘要

The effects of different fibric acid derivatives (bezafibrate, clofibrate, clofibric acid, fenofibrate, fenofibric acid and gemfibrozil) on human organic anion transporting-polypeptide 1B1 (OATP2, OATP-C, SLC21A6), multidrug resistance protein 2 (MRP2/ABCC2) and MDR1-type P-glycoprotein (P-gp/ABCB1) were examined in vitro. Cyclosporin A (a known inhibitor of OATP1B1 and P-gp), MK-571 (a known inhibitor of MRP2) and cimetidine (an organic cation) were also tested. Bezafibrate, fenofibrate, fenofibric acid and gemfibrozil showed concentration-dependent inhibition of estradiol 17-beta-D-glucuronide uptake by OATP1B1-stably transfected HEK cells, whereas clofibrate and clofibric acid did not show any significant effects up to 100 microM. Inhibition kinetics of gemfibrozil, which exhibited the most significant inhibition on OATP1B1, was shown to be competitive with a Ki = 12.5 microM. None of the fibrates showed any significant inhibition of MRP2-mediated transport, which was evaluated by measuring the uptake of ethacrynic acid glutathione into MRP2-expressing Sf9 membrane vesicles. Only fenofibrate showed moderate P-gp inhibition as assessed by measuring cellular accumulation of vinblastine in a P-gp overexpressing cell-line. Cyclosporin A significantly inhibited OATP1B1 and P-gp, whereas only moderate inhibition was observed on MRP2. The rank order of inhibitory potency of MK-571 was determined as OATP1B1 (IC50: 0.3 microM) > MRP2 (4 microM) > P-gp (25 microM). Cimetidine did not show any effects on these transporters. In conclusion, neither MRP2- nor P-gp-mediated transport is inhibited significantly by the fibrates tested. Considering the plasma protein binding and IC50 values for OATP1B1, only gemfibrozil appeared to have a potential to cause drug-drug interactions by inhibiting OATP1B1 at clinically relevant concentrations.
机译:不同纤维酸衍生物(苯扎贝特,氯贝特,氯贝酸,非诺贝特,非诺贝特酸和吉非贝齐)对人体有机阴离子转运多肽1B1(OATP2,OATP-C,SLC21A6),耐多药蛋白2(MRP2 / ABCC2)和在体外检查了MDR1型P-糖蛋白(P-gp / ABCB1)。还测试了环孢菌素A(一种已知的OATP1B1和P-gp抑制剂),MK-571(一种已知的MRP2抑制剂)和西咪替丁(一种有机阳离子)。苯扎贝特,非诺贝特,非诺贝特酸和吉非贝齐对OATP1B1稳定转染的HEK细胞摄取雌二醇17-β-D-葡糖醛酸具有浓度依赖性抑制作用,而在100 microM以下,氯贝贝特和氯贝酸未显示任何显着影响。对OATP1B1表现出最显着抑制作用的吉非贝齐的抑制动力学表现出与Ki = 12.5 microM竞争。没有任何一种贝特类药物显示出对MRP2介导运输的任何显着抑制作用,这是通过测量乙炔酸谷胱甘肽对表达MRP2的Sf9膜囊泡的摄取来评估的。如通过测量过表达P-gp的细胞系中长春碱的细胞蓄积评估,只有非诺贝特显示出中等的P-gp抑制作用。环孢菌素A显着抑制OATP1B1和P-gp,而在MRP2上仅观察到中度抑制。确定MK-571抑制力的等级顺序为OATP1B1(IC50:0.3 microM)> MRP2(4 microM)> P-gp(25 microM)。西咪替丁对这些转运蛋白没有显示任何作用。总之,受测试的贝特蛋白对MRP2和P-gp介导的转运均无明显抑制作用。考虑到血浆蛋白结合和OATP1B1的IC50值,只有吉非贝齐似乎有可能通过在临床相关浓度下抑制OATP1B1来引起药物相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号